Collectively, these results demonstrate that treatment with ARV@PDSA not only substantially inhibited tumor growth by inhibiting BRD4 and c‐Myc but also showed a superior anti‐tumor therapy strategy than free PROTACs. Here, MYC is linked to neoplasm.